Medication Management for Anorexia Nervosa

Anorexia nervosa is a serious, potentially life-threatening eating disorder marked by restriction of food intake, an intense fear of weight gain, and a disturbance in the way body weight or shape is experienced. Anorexia nervosa has one of the highest mortality rates of any psychiatric illness and requires specialized, individualized care. 

The foundation of treatment includes weight restoration, evidenced-based eating disorder psychotherapy, nutritional rehabilitation and close medical monitoring. While no medication is a substitute for this treatment, in certain clinical situations medications can address specific symptoms or co-occurring conditions. Medications function as one component of a comprehensive, coordinated plan rather than as a stand-alone treatment, and their use should be guided by an experienced eating disorder specialist. 

The content of this blog is intended for general educational purposes only and does not constitute medical advice; it is not a substitute for evaluation and treatment by qualified clinicians.

Are There FDA-Approved Medications for Anorexia Nervosa?

An FDA-approved use means the U.S. Food and Drug Administration (FDA) has reviewed clinical trial data and determined a medication is safe and effective for a specific condition. While the FDA has approved drugs for bulimia nervosa and binge-eating disorder, there are currently no FDA-approved medications specifically for anorexia nervosa. Clinicians do prescribe medications during the treatment of anorexia nervosa, but the goal is usually to address a co-occurring condition, such as major depressive disorder, rather than the eating disorder itself. 

“Off-label” use means a clinician prescribes a medication for a specific purpose, population or dose that the FDA has not formally reviewed. Off-label prescribing is common and often clinically appropriate, but the supporting evidence is more limited than for an approved medication. More than half of adolescents with restrictive eating disorders are prescribed psychiatric medications, most often in an attempt to manage comorbid depression or anxiety. For anorexia nervosa, essentially all medication use is off-label.

Efforts to develop drug treatments for anorexia nervosa have been largely disappointing, with medications failing to outperform placebo on eating, weight, or psychological outcomes. By contrast, eating disorder-focused psychotherapies, such as cognitive behavioral therapy or family-based treatment, demonstrated meaningful weight gain and symptom reduction and are therefore recommended first-line treatments. Because many of the psychological and physiological symptoms of anorexia nervosa stem from starvation itself, medical stabilization and improvement in nutrition with weight restoration are the most important first steps; some psychological symptoms improve simply with renourishment.

Whether and what to prescribe depends on many factors: the person’s physical health and medical stability, their specific symptoms and comorbidities, their age, and prior treatment history. Medically unstable patients – for example, those with low heart rate or electrolyte abnormalities – require stabilization first. During renourishment, there needs to be close monitoring for refeeding syndrome, a dangerous shift in fluids and electrolytes characterized by low phosphorus and potential heart arrhythmias, seizures and death. Medications can worsen cardiovascular abnormalities and increase risk of seizures. Decisions about medication use in anorexia nervosa are best made by an experienced eating-disorder provider.

There is currently no medication that cures anorexia nervosa or restores weight on its own. The idea that any drug leads to recovery or is a shortcut to weight gain misrepresents the evidence – medication is just one supporting component of a comprehensive plan.

When Medication May Be Part of Anorexia Nervosa Treatment

Because psychiatric medications do not treat the core features of anorexia nervosa, prescribing a medication is usually reserved for situations where another specific symptom is present. A psychiatrist may consider medication when a patient has depression, anxiety or obsessive-compulsive symptoms that do not improve with weight gain. They may also consider medication when there is severe anxiety or agitation that prevents refeeding. Medications may be prescribed to help with persistent, intrusive or irrational eating-disorder thoughts. 

There is no standard medication regimen for anorexia nervosa. Malnutrition and low body weight alter how the body handles medications, which is why it is important for providers to exercise caution when prescribing. Severe malnutrition can change body composition, drug absorption and liver or kidney clearance. This can lead to altered drug responses, such as elevated drug levels or decreased efficacy, which necessitate the use of smaller doses and close monitoring. 

Medication decisions need to be evaluated throughout the treatment process. Because many psychological and physiological symptoms of anorexia nervosa arise from starvation and improve with renourishment, a medication started at the beginning of treatment may become unnecessary after weight restoration. Or a comorbidity that was masked by malnutrition may become apparent only after weight gain. Medication needs to be assessed and adjusted as a person’s physical and psychological needs change during recovery. Safe medication management depends on a coordinated, multidisciplinary approach, which includes medical, psychological and nutritional treatment, and family involvement when appropriate.

Common Medications Clinicians May Consider

Please remember, all of the following medications are used off-label and are directed at specific symptoms or co-occurring conditions, not at treating anorexia nervosa itself.

Antidepressants

Selective Serotonin Reuptake Inhibitors (SSRIs) are prescription antidepressants that block brain cells from reabsorbing serotonin, a chemical messenger in the brain. By stopping the reabsorption, more serotonin is available to carry signals between neurons. SSRIs have not shown benefit compared to placebo for eating, weight or cognitive rigidity in anorexia nervosa. However, they may be considered for a co-occurring depression, anxiety, or obsessive-compulsive disorder that persists despite nutritional and psychological care for anorexia nervosa. Of the SSRIs, fluoxetine has the most supporting data, though some reports show benefit only after at least partial weight restoration. 

Due to low serotonin levels, lack of specific nutrients, and receptor changes, SSRIs may not be effective in acutely malnourished patients. Mood and obsessive thoughts may improve with weight gain alone. For these reasons, medication treatment may be deferred until the response to weight restoration has been evaluated. 

Mirtazapine is a tetracyclic antidepressant that is FDA approved for the treatment of major depressive disorder, and may have side effects of increased appetite and weight gain. Although it may be useful in treating comorbid depression, mirtazapine has not been shown to increase weight in anorexia nervosa.

Atypical Antipsychotics 

Atypical antipsychotics, also known as second-generation antipsychotics, are prescription medications that are FDA approved for schizophrenia and bipolar disorder, and as add-on treatments for major depressive disorder.

Olanzapine is an atypical antipsychotic and one of the most-studied medications in anorexia nervosa. By balancing several neurotransmitters in the brain, including dopamine and serotonin, olanzapine may help decrease obsessive thoughts, anxiety, or rigidity around food and body image which interfere with treatment. Some research into the effectiveness of olanzapine suggests reduced preoccupation with body image and reduced anxiety around meals. Other trials show no effect on weight or eating disorder thoughts. Potential side effects, such as sedation, cardiac abnormalities and metabolic monitoring, require close medical oversight. It is important to note that although weight gain is a potential side effect of olanzapine, in one large randomized trial there was only a modest increase in weight compared to placebo.

Aripiprazole is another atypical antipsychotic that may be used off-label in anorexia nervosa. The supporting evidence for using aripiprazole comes from case series and retrospective studies, not from controlled trials, but the medication is worth considering in carefully selected or treatment-resistant cases. By only partially blocking dopamine, it works differently from the other second-generation antipsychotics such as olanzapine. This may explain its reported effect on rigid, fear-driven thinking about food. Given the lack of data, however, aripiprazole is not considered a first-line or stand-alone treatment.

Short-Term Anxiety Support

Medication for acute anxiety may occasionally be considered in limited circumstances. For example, hydroxyzine or benzodiazepines such as lorazepam may be used for severe acute anxiety or agitation, or to reduce eating-related anxiety that obstructs refeeding. The evidence for this practice is limited and the medications may have side effects such as sedation that require close monitoring. Other side effects include dizziness, low blood pressure and increased risk of falling. For these reasons, medications for acute anxiety are best limited to short-term, targeted use rather than to regular, daily use.

Why Therapy, Nutrition, and Medical Care Come First

Therapy, nutritional rehabilitation and medical care come first because they are the only evidence-based treatments shown to address anorexia nervosa. Psychiatric medication supports, not replaces, these foundations of care.

Children and adolescents: family-based treatment (FBT) 

This outpatient treatment, delivered over approximately 6-12 months, guides parents in restoring their child’s weight. Once weight is restored and maintained, age-appropriate autonomy over eating is gradually returned to the child. 

Adults: eating disorder–focused psychotherapy

Structured individual therapy, such as enhanced cognitive-behavioral therapy (CBT-E), targets the behaviors that sustain an eating disorder in order to improve weight and reduce eating disorder symptoms.

Nutritional rehabilitation and supervised meal support

Medical providers review data, such as height/weight history and growth charts, to set individualized targets for weekly weight gain and long-term weight ranges. A registered dietitian guides meal plans at different stages of recovery. Gaining 1-2 pounds per week is a typical goal during outpatient treatment. Supervised meal support may be useful to assist with the completion of meals.

Medical care

Regular monitoring by an experienced eating disorder specialist is important throughout treatment. Evaluations may include orthostatic vital signs (a series of blood pressure and pulse measurements taken before and after a change in body position), blood work and an electrocardiogram (ECG). As described earlier, special care needs to be taken during renourishment to prevent refeeding syndrome. The frequent monitoring of electrolytes and preemptive administering of phosphorus may be considered depending on the degree of malnourishment.

Medication Safety and Medical Monitoring

Malnutrition alters how the body processes medications and increases the risk of serious adverse effects to drugs. Medications used in anorexia nervosa require careful assessment and ongoing follow-up to monitor safety.

Most psychiatric medications are reasonably well tolerated by patients with anorexia nervosa. Low weight and metabolic abnormalities, however, indicate a need for caution. In a malnourished individual, cardiovascular abnormalities, such as low blood pressure or a prolonged QTc interval on an ECG, may already be present and could be worsened by a new drug. Clinicians will assess a patient’s physical health before prescribing, choose conservative doses, and follow patients closely as their weight and clinical picture change.

The psychiatric medications used in anorexia nervosa may cause the following side effects: 

• Sedation – SSRIs, olanzapine or short-term medications for anxiety may all cause sedation.
• Metabolic effects – Elevations in blood glucose and/or lipid levels can occur with antipsychotics such as olanzapine or aripiprazole.
• Drug interactions and additive risks – The combination of taking several medications and the potential for electrolyte disturbances in anorexia nervosa can compound the risk of dangerous heart rhythms. 
• Mood and behavior changes – Monitoring for new or worsening depression, anxiety, agitation, or suicidal thoughts should occur whenever an antidepressant or other psychotropic medication is added.

It is important to emphasize that ongoing medical monitoring, including for mental health side effects, becomes even more important when medications are added. 

Informed conversations matter. They may be even more significant in anorexia nervosa where medications are used off-label and with modest benefits. Before starting or changing any medication, patients and families are encouraged to ask their treatment team any questions they may have – especially as worries about a drug’s effects on weight can undermine adhering to recommendations. 

When to Seek Immediate Help

Certain physical symptoms can signal that the body is becoming dangerously unstable and warrant same-day medical assessment or an emergency visit. These symptoms can include:

• Fainting, near-fainting, or collapse
• Chest pain, palpitations, or an irregular or very slow heartbeat
• Confusion, disorientation, or trouble thinking clearly
• Seizures
• Severe weakness or inability to stand or walk
• Signs of dehydration such as very little urination, extreme thirst, dizziness on standing, or a racing pulse

When there is an immediate safety concern, always call 911 or go to the nearest emergency department. When there is a mental health crisis, the 988 Suicide and Crisis Lifeline can be reached by calling or texting 988 for round-the-clock support.

Prompt recognition and treatment of medical and psychiatric complications prevent further deterioration and save lives. Early identification and specialized care are associated with better outcomes and more rapid recovery. So, reaching out to an experienced eating disorder clinician, rather than waiting to see if things improve on their own, supports both safety and long-term recovery.

Questions to Ask an Eating Disorder Psychiatrist

Asking questions helps patients and their families share in making medication decisions. And shared decision-making and clearly defined, common treatment goals among patient, family, and clinicians are important ways to improve treatment success and safety in eating disorders.

Some questions to consider:

• What is this medication meant to help, and what realistic benefit can be expected?
• What are the common and serious side effects, and how will they be monitored?
• How will this medication interact with the nutritional and psychological parts of the plan, and when will its usefulness be reassessed?
• Who should we contact if symptoms worsen or if we have concerns?
• What warning signs should prompt an urgent call? 

Keeping communication open among the patient, family, and the full team – including psychiatrist, therapist, primary care physician, and dietitian – supports both safety and recovery. Clinicians want patients and their loved ones to ask questions and to be a part of the process of recovery.